Product
IL-15 Superagonist
1 clinical trial
4 indications
Indication
Platinum-resistant Ovarian CancerIndication
Recurrent Ovarian CancerIndication
Ovarian CancerIndication
RecurrentClinical trial
A Phase 1b Study of Cytokine-Induced Memory Like (CIML) Natural Killer (NK) Cell Therapy in Combination With N-803 (Il-15 Superagonist) in Recurrent Ovarian CancerStatus: Not yet recruiting, Estimated PCD: 2026-11-30